To report SUSPECTED ADVERSE REACTIONS, contact Intercept Pharmaceuticals, Inc. at 1-844-782-ICPT or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Limited has received the work order under Component-B of PM-KUSUM scheme from Haryana Renewable Energy Department (HAREDA) ...